AUSTRALIA AND NEW ZEALAND SURGICAL AND RESPIRATORY MASK MARKET ANALYSIS

Market Challenges And Opportunities

Australia & New Zealand Surgical and respiratory Mask Market – Driver

Increasing number of surgical procedures

Prevalence of increasing surgeries leads to admissions in hospitals which tends to the use of surgical masks and respiratory masks by the general practitioners or by patients. For instance, according to the Australian Institute of Health and Welfare, Emergency admissions involving surgery accounted for 387,000 hospitalizations in 2020–2021; 86% (332,000) of these occurred in public hospitals while 14% (54,900) did so in private ones. the top three causes of surgery-related emergency admissions. Some jurisdictions may expect significant increases in emergency department traffic between 2020 and 21 as a result of the activity's 6.9% growth from 2019 to 2020.

Australia & New Zealand Surgical and respiratory Mask Market – Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets.

The COVID-19 pandemic had a positive impact on the Australia & New Zealand surgical and respiratory mask market owing to the increasing number of infectious diseases such as flu and viral during COVID time. The COVID-19 pandemic has led to an acute shortage of surgical and respirator masks. In March 2020, The Centers for Disease Control and Prevention, a national public health agency of the United States stated that consideration can be made to use N95 respirators beyond the manufacturer-designated shelf life for the care of patients with COVID-19, tuberculosis, measles, and varicella.

Australia & New Zealand Surgical and respiratory Mask Market: Restraints

Limited product availability and product visibility

Due to long-term contracts between suppliers and manufacturers, product visibility is constrained in both nations. This has made it more difficult for other multinational firms who compete in the market for medical goods to collaborate with them. Whereas the limited product availability in the pandemic time also restricted the growth of the market. So, increase in the distribution agreement with the key players along with product availability in the market. For instance, in April 2020, according to the Queensland Government of Northeastern Australia, an independent government-owned statutory body, Australia is experiencing a shortage of disposable particulate respirators as a result of rising demand from the public and health care professionals, as well as the temporary closure of numerous Chinese manufacturers. Moreover, the number of disposable medical product suppliers in Australia and New Zealand is low, which limits product differentiation and restrains market growth.